Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

22.70
-1.4600-6.04%
Volume:633.01K
Turnover:14.82M
Market Cap:2.71B
PE:-10.59
High:24.63
Open:24.60
Low:22.70
Close:24.16
52wk High:42.21
52wk Low:21.02
Shares:119.54M
Float Shares:90.76M
Volume Ratio:0.55
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1442
EPS(LYR):-1.7211
ROE:-36.81%
ROA:-20.11%
PB:4.30
PE(LYR):-13.19

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Invivyd (IVVD), NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Sep 30

NewAmsterdam Pharma Doses First Patient in Phase 2b Spinoza Trial of Obicetrapib in Preclinical Alzheimer’s Disease

Reuters
·
Sep 29

Menarini Group & Newamsterdam Pharma Receive European Commission Approval for Ubeslo and Evlarco

Reuters
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)

TIPRANKS
·
Sep 22

NewAmsterdam Pharma Gets EU Approval for Ubeslo, Evlarco

MT Newswires Live
·
Sep 21

NewAmsterdam Pharma Price Target Maintained with a $52.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 08

Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Newamsterdam Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Sep 04

NewAmsterdam Pharma Grants Inducement Share Options for 52,900 Shares at $24.92 Each

Reuters
·
Sep 04

NewAmsterdam Pharma to Present Phase 3 Obicetrapib Trial Data at ESC Congress 2026

Reuters
·
Aug 26

NewAmsterdam Pharma CSO Johannes Kastelein Disposes of 125,000 Shares for USD 3.36 Million

Reuters
·
Aug 26

NewAmsterdam Pharma Amends 8-K to Disclose COO Douglas Kling Separation, Advisor Agreement Terms

Reuters
·
Aug 15

NewAmsterdam Pharma Appoints Robert Gunning Principal Accounting Officer

Reuters
·
Aug 15

Needham Remains a Buy on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Aug 08

NewAmsterdam Pharma Grants 28,000 Inducement Share Options at $27.79 to New Hires

Reuters
·
Aug 07

RBC Adjusts NewAmsterdam Pharma PT to $50 From $51, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 06

Stifel Nicolaus Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Aug 06

NewAmsterdam Pharma Company N.V. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05